← back to search

Na Man

ShanghaiTech University · CN
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Cancer-related gene regulation, Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, and Protein Degradation and Inhibitors.
h-index
19
citations
7,403
works
46
NIH funding
primary concept
email

Recent publications

Structural insights into the regulation of monomeric and dimeric apelin receptor
Nature Communications 2025cited by 13position: middledoi
The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression
Journal of Clinical Investigation 2023cited by 19position: middledoi
Epigenetic and Transcriptional Regulation of Innate Immunity in Cancer
Cancer Research 2022cited by 11position: middledoi
RAC1 plays an essential role in estrogen receptor alpha function in breast cancer cells
Oncogene 2021cited by 53position: middledoi
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
JCI Insight 2021cited by 19position: firstdoi
PRMT5-mediated histone arginine methylation antagonizes transcriptional repression by polycomb complex PRC2
Nucleic Acids Research 2020cited by 69position: middledoi
TAF1 plays a critical role in AML1-ETO driven leukemogenesis
Nature Communications 2019cited by 54position: middledoi
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes
Cell Reports 2018cited by 227position: middledoi
CARM1 Is Essential for Myeloid Leukemogenesis but Dispensable for Normal Hematopoiesis
Cancer Cell 2018cited by 78position: middledoi
Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis
Proceedings of the National Academy of Sciences 2018cited by 24position: middledoi
Caspase-3 controls AML1-ETO–driven leukemogenesis via autophagy modulation in a ULK1-dependent manner
Blood 2017cited by 56position: firstdoi
Loss of Asxl2 leads to myeloid malignancies in mice
Nature Communications 2017cited by 30position: middledoi
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity
eLife 2016cited by 68position: middledoi
Loss of p300 accelerates MDS-associated leukemogenesis
Leukemia 2016cited by 39position: middledoi
Arginine methyltransferase PRMT5 is essential for sustaining normal adult hematopoiesis
Journal of Clinical Investigation 2015cited by 150position: middledoi
The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis
Frontiers in Oncology 2015cited by 136position: middledoi
Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression
Blood 2015cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Stephen D. Nimer · University of Miami15 papers (2015–2023)Fan Liu · Jiangnan University8 papers (2015–2022)Daniel Karl · Precision BioSciences (United States)7 papers (2017–2023)Sarah Greenblatt · Genomics Institute of the Novartis Research Foundation7 papers (2015–2019)Jun Sun · University of Miami5 papers (2019–2022)Mingjiang Xu · The University of Texas Health Science Center at San Antonio5 papers (2016–2021)Pierre-Jacques Hamard · Memorial Sloan Kettering Cancer Center5 papers (2015–2021)Stéphanie Duffort · University of Miami5 papers (2018–2023)Lan Wang · South China Agricultural University5 papers (2015–2019)Ye Xu · Xinjiang Production and Construction Corps5 papers (2018–2021)Concepción Martínez · University of Miami5 papers (2018–2021)Glòria Mas Martín · University of Miami4 papers (2019–2023)Adnan K. Mookhtiar · Sylvester Comprehensive Cancer Center4 papers (2018–2023)Xiao‐Jian Sun · Southwest University4 papers (2015–2019)Ramin Shiekhattar · University of Miami4 papers (2016–2023)Yurong Tan · Central South University3 papers (2015–2017)Hidehiro Itonaga · Sylvester Comprehensive Cancer Center3 papers (2021–2023)Madhavi Tadi · Sylvester Comprehensive Cancer Center3 papers (2015–2018)Camilo Martinez · Stony Brook University Hospital3 papers (2016–2019)Feng‐Chun Yang · The University of Texas at San Antonio Health Science Center3 papers (2017–2021)